Alnylam Pharmaceuticals (ALNY) Q1 2020 Earnings

6FebConfirmed
Q2 2019
Q3 2019
Q4 2019
Q1 2020
-2.57
-2.29
-2.01
-1.73

Details

Expected EPS
-2.28
Actual EPS
-2.57
Surprise EPS
-0.29
Surprise Percent
+12.72%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.57 per share for Q1 2020.

0 Comments

Share your thoughts